2019
DOI: 10.1007/s10549-019-05132-z
|View full text |Cite
|
Sign up to set email alerts
|

National consensus recommendations on patient-centered care for ductal carcinoma in situ

Abstract: Purpose The purpose of this research was to generate recommendations on strategies to achieve patient-centered care (PCC) for ductal carcinoma in situ (DCIS). Methods Thirty clinicians (surgeons, medical/radiation oncologists, radiologists, nurses, navigators) who manage DCIS and 32 DCIS survivors aged 18 or older were nominated. Forty-six recommendations to support PCC for DCIS were derived from primary research, and rated in a two-round Delphi process from March to Ju… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 39 publications
1
9
0
Order By: Relevance
“…At the same time, women identified or suggested approaches by which clinicians can more consistently achieve PCC for DCIS. Those recommendations are consistent with national consensus recommendations on PCC for DCIS generated by Delphi process involving 30 clinicians of multiple specialties who manage DCIS and 32 DCIS survivors …”
Section: Discussionsupporting
confidence: 68%
“…At the same time, women identified or suggested approaches by which clinicians can more consistently achieve PCC for DCIS. Those recommendations are consistent with national consensus recommendations on PCC for DCIS generated by Delphi process involving 30 clinicians of multiple specialties who manage DCIS and 32 DCIS survivors …”
Section: Discussionsupporting
confidence: 68%
“…20,34 Although multiple online educational resources do exist for patients diagnosed with DCIS, few have focused on enhancing communication between patients and providers to support optimal decision-making about DCIS treatment. 35,36 Decision support tools, which can help patients to weigh the risks and benefits of different treatment options while accounting for individual preferences, represent a promising approach. An interactive decision support tool (https://dciso ptions.org/dst) was recently developed for this purpose and is available to women diagnosed with DCIS who are considering their treatment options.…”
Section: Discussionmentioning
confidence: 99%
“…There is also evidence that communication with a provider is positively related to the likelihood of patients with breast cancer more correctly estimating their risk of recurrence 33 . However, communicating cancer‐related risk is complex, and improved methods to effectively communicate information about DCIS and its associated risks to those affected should be a priority 20,34 . Although multiple online educational resources do exist for patients diagnosed with DCIS, few have focused on enhancing communication between patients and providers to support optimal decision‐making about DCIS treatment 35,36 .…”
Section: Discussionmentioning
confidence: 99%
“…While some experts have advocated for changes to terminology for lesions with low malignant potential [86], other experts argue that use of non-cancer labels may be deceptive and limit informed decision-making [87]. Using a two-round Delphi of 27 women with DCIS and 29 clinicians, we generated Canadian consensus recommendations on PCC for DCIS, which included a recommendation to refine DCIS nomenclature [88], In future research, we plan to engage international experts including DCIS survivors, clinicians, cancer staging and classification agencies, cancer societies, and breast cancer trials groups and advocacy groups in identifying the potential benefits and harms of various DCIS labels.…”
Section: Discussionmentioning
confidence: 99%